The Nigeria Centre for Disease Control (NCDC) says it is ready to host the first Lassa fever international conference, in the country.
In a statement on Tuesday in Abuja, by the Chief Executive Officer, NCDC, Dr. Chikwe Ihekweazu says this was to mark 50 years since the Lassa fever virus was first isolated in a town in Nigeria.
Mr Ihekweazu said that the conference, to be organised in partnership with other stakeholders, would hold between Jan. 16 and Jan. 17, in Abuja.
“The opportunity created by the ‘anniversary’ of the discovery of the virus, is being used to bring researchers and practitioners from across the world.
“The researchers and practitioners will share and appraise global efforts towards the control of the Lassa fever virus disease,” Ihekweazu said.
According to him, the conference will also be an opportunity to increase global health focus on the disease, which was found mostly in West Africa.
The NCDC chief executive added that as awareness and disease surveillance systems improve across West African countries, more cases were being detected.
According to him, this has created an increased sense of urgency for the global health community to do more through better prevention, disease detection, and control as well as case management efforts.
“In 2018, the World Health Organisation launched its Research and Development blueprint, highlighting the potential of Lassa fever and a selected list of diseases to lead to public health emergencies.
“This plan highlights the absence of efficacious drugs and vaccines, and further highlights the urgent need for accelerated research and development,” he said.
Mr Ihekweazu further said that the conference would afford the global audience to learn about efforts towards new strategies to prevent transmission of the virus from rodents to human.
He also said that new approaches to mitigating hospital transmission of the disease as well as new insights into the social context of Lassa transmission would be known.
The NCDC boss said that current efforts on new Lassa fever vaccines, therapeutics and clinical treatment approaches would also be key highlights at the conference.
The conference would bring stakeholder together for a meeting full of learning and exchange of ideas.